Joanne M. Mankor

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters et al. · Science Immunology · 2023 · 93 citations · Full text

Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials

Joanne M. Mankor, Maria Disselhorst, Myrthe Poncin et al. · EBioMedicine · 2020 · 41 citations · Full text

Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC

Sophie M. Ernst, Joanne M. Mankor, Job van Riet et al. · Journal of Thoracic Oncology · 2022 · 40 citations · Full text

Tobacco Cessation, Tobacco Control, Tobacco Use +9

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples

Joanne M. Mankor, Marthe S. Paats, Floris H. Groenendijk et al. · British Journal of Cancer · 2020 · 30 citations · Full text

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

Floris Dammeijer, Cornedine J. de Gooijer, Mandy van Gulijk et al. · EBioMedicine · 2021 · 26 citations · Full text